Clinical Trial Update: A Deep Learning Method to Evaluate QT on Ribociclib

View source ↗

Summary

A completed study evaluating a deep learning approach to assess the QT interval effects of ribociclib in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ribociclib (ribociclib)

Snippet

Sponsor: CMC Ambroise Paré | Conditions: Breast Cancer, Ribociclib | Status: COMPLETED